BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31329498)

  • 1. Primary Ovarian Diffuse Large B Cell Lymphoma: Report of a Rare Case in a Young Female.
    Zaidi A; Gupta P; Saha PK; Rajwanshi A; Srinivasan R; Das A
    J Adolesc Young Adult Oncol; 2019 Dec; 8(6):702-706. PubMed ID: 31329498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary ovarian non-Hodgkin's lymphoma.
    Arnogiannaki N; Grigoriadis C; Zygouris D; Androutsopoulos G; Derdelis G; Terzakis E
    Eur J Gynaecol Oncol; 2011; 32(4):441-2. PubMed ID: 21941973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
    Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
    Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torquated large ovarian lymphoma as a cause of acute abdomen: a case report of diffuse large B-cell ovarian lymphoma with a germinal center B-cell-like phenotype.
    Živković K; Marton I; Tikvica Luetić A; Gašparov S; Horvat Pavlov K; Sović L; Cerovac A; Habek D
    Wien Med Wochenschr; 2022 May; 172(7-8):181-183. PubMed ID: 33616796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian non-Hodgkin lymphoma: case study.
    Chasiotis I; Lambropoulos M; Elmazis C; Vasileiou M; Mpouklis A
    Eur J Gynaecol Oncol; 2011; 32(6):708-9. PubMed ID: 22335045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An atypical presentation of an ovarian lymphoma: a case report.
    Ekanayake CD; Punchihewa R; Wijesinghe PS
    J Med Case Rep; 2018 Nov; 12(1):338. PubMed ID: 30424819
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
    Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations.
    Kakkar A; Rajeshwari M; Bhethanabhotla S; Kaur K; Jain D; Gogia A; Ray R; Seth A
    J Cancer Res Ther; 2015; 11(4):977-9. PubMed ID: 26881561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigastralgia revealing primary pancreatic large B-cell lymphoma in a young patient: about a case].
    Amine B; Najat L; Ilias T
    Pan Afr Med J; 2018; 31():161. PubMed ID: 31065319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal Diffuse Large B-Cell Lymphoma Presenting as Laryngeal Stenosis.
    Tang Y; Li P; Cua D; Lai J
    In Vivo; 2020; 34(1):255-260. PubMed ID: 31882486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
    O'Malley DP; Auerbach A; Weiss LM
    Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20 negative primary diffuse large B cell lymphoma of breast: Role of Pax-5.
    Shukla S; Awasthi NP; Singh P; Husain N
    J Cancer Res Ther; 2015; 11(3):658. PubMed ID: 26458662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lymphoma of the ovary.
    Elharroudi T; Ismaili N; Errihani H; Jalil A
    J Cancer Res Ther; 2008; 4(4):195-6. PubMed ID: 19052394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of primary hepatic diffuse large B-cell lymphoma: a report of seven cases and a literature review.
    Zheng J; Hou Y; Zhou R; Zhong D
    Int J Clin Exp Pathol; 2015; 8(10):12955-60. PubMed ID: 26722490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin malignant lymphoma revealed by an ovarian tumor case report and review of the literature.
    Weingertner AS; Hamid D; Roedlich MN; Baldauf JJ
    Gynecol Oncol; 2004 Dec; 95(3):750-4. PubMed ID: 15581998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.